BioShin

China
Shaxi, Fujian, China, 200126

Company profile

BioShin company profile

BioShin is a wholly owned subsidiary of Biohaven Pharmaceuticals, a public biotech company. BioShin is a clinical stage biopharmaceutical company focused on developing medicines. It has proven leadership from global industry and academic settings and a portfolio of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases, including rare disorders.

Business identity

Contact email
[email protected]
Operating status
Closed
Company type
For Profit
Employee range
1-10 employees
Founded
2013-01-01, Year

Headquarters

Postal code
200126
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$60M
Last funding
Series A / $60M / 2020-09-28
Last equity funding
Series A / $60M
Investors
5
Lead investors
1
Founders
1
Articles
2
Closed on
2021-11-09

Founders and investors

Founders

Karl Lintel

Lead investors

OrbiMed

Investors

Cormorant Asset ManagementHBM Healthcare InvestmentsOrbiMedSurveyor CapitalSuvretta Capital Management